Science Applied to. Saving Lives. Uganda s Progress in. Implementing Lab. Biosafety / Biosecurity

Similar documents
UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI

NIGERIAN EXPERIENCE OF THE BIOLOGICAL AND TOXIN WEAPONS CONVENTION

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Biorisk reduction: A WHO approach

The Laboratories Role in Global Health

6/6/2012. General Information (3)

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?

Uganda DHIS2 Case Based Surveillance System: Would Have Detected the 2016 Yellow Fever Outbreak in Uganda

JOINT WEST AFRICA RESEARCH GROUP (JWARG): A MILITARY SUPPORT OF CIVILIAN COLLEAGUES AFTER WEST AFRICA EBOLA OUTBREAK

BIOSAFETY NEWS 1 st Edition

Canada-Kyrgyz Cooperation to Combat BW Proliferation and the Spread of Infectious Diseases

GLOBAL HEALTH ACTIVITIES THROUGH DECEMBER 2016

The Current State of Biosafety in the African region

Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria.

Implications of Life Sciences R&D for Global Health Security

CDC s Commitment to National Laboratory Systems to Achieve Global Health Security

Targeting HIV Settings Through PEPFAR. Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group

Travel and transport risk assessment. Preparedness for potential outbreak of

Idris Al Abaidani IHR Focal Point, Oman

APEC Ministerial Meeting on Avian and Influenza Pandemics Da Nang, Viet Nam, 4-6 May 2006

Disease Prevention, Detection & Response During Public Health Emergencies

CAPACITY BUILDING in DETECTION, DIAGNOSIS and CONTAINMENT of INFECTIOUS DISEASE: INDONESIA S EXPERIENCE, CHALLENGES and NEEDS

Biosafety and Bioethics

Peter Gerner-Smidt, M.D., D.M.S. Enteric Diseases Laboratory Branch, CDC

VHFs OUTBREAK CONTROL: Uganda Case Study

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine

Progress Toward Quality Management Systems Implementation and Laboratory Accreditation in the Caribbean region

Laboratory diagnosis Surveillance and outbreak detection Outbreak investigation

GPHIN (intelligence tool) & GOARN (operational arm) of IHR (2005)

OIE Collaborating Centers Reports Activities

Present State and Measures against Infectious Diseases in Tokyo

BD/PEPFAR Laboratory Strengthening Program IOM MEETING 13 APRIL 2010 PRETORIA SOUTH AFRICA DANNI RAMDUTH

Bioterrorism: Public Health Challenges (Module 1: Bioterrorism Overview and History of Biological Warfare)

Global Health Security and Domestic Preparedness:

Quarterly Epidemiological Bulletin

Science. Systems Policy Process Programs People

EBOLA VIRUS DISEASE. On 26 May 2017, no new confirmed or probable EVD cases were reported. The last confirmed case was reported on 11 May 2017.

Potential Threats from Biotechnology and Life Sciences: What is Dual-Use Research?

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013

2016/LSIF/FOR/002 Strengthening Surveillance for Antimicrobial Resistance and Healthcare-Associated Infections

IHR News. The WHO quarterly bulletin on IHR implementation. 30 June 2009, No. 7

IHR (2005) Compliance: Laboratory Capacities and Biological Risks

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

ROLLING BACK THE HIV EPIDEMIC: THE CRITICAL ROLE OF THE LABORATORY.

Dr. Jim LeDuc Director Galveston National Laboratory University of Texas Medical Branch. 29 October 2015

Public Safety and Health Cooperation from the Canadian Perspective

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

CDC s Global Disease Detection Program

GLOBAL HEALTH SECURITY AGENDA ROADMAP VIETNAM

GLOBAL HEALTH SECURITY AGENDA CAMEROON ROADMAP

The World Health Organization: Does it have a Role in Critical Illness?

The Threat of Agroterrorism and Zoonotic Diseases in the United States

Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions

FAO influenza surveillance and control in animals Strategy and its implementation

Name: Mah d M. S. Shafei Tel:

1966 CDC assessment of US Health

Opportunities for the Future of Healthcare and Public Health Preparedness, Response, and Recovery

Summary of current outbreak in Guinea, Liberia and Sierra Leone

PLAGUE OUTBREAK. Madagascar. External Situation Report 01. Grade

Proliferation Threats from Biotechnology: What is Dual-Use Research?

The Netherlands 2016 Implementation of Article VII of the BWC

Infection Control in real life

Using Platforms and Partnerships to

Improving Access to Healthcare in the Developing World. Renuka Gadde VP, Global Health 21 October 2012

Federal Select Agent Program Overview

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 6, 13 September 2012

Public Health Emergencies: Mass Dispensing in the Community

Indonesia s Experience, Challenge and Needs: Ensuring Access to Equipment and Technology:

Implementation of the International Health Regulations (2005)

lated at the 6 regions/zobas before emerging disease include epidemic prone diseases

THE WAY AHEAD. To advance fundamental knowledge in the field of. to the understanding, and the prevention of and treatment of human diseases

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS

Stepwise Process for Improving the Quality of HIV-related POCT Sites Towards Certification

International Activities of the Government of Canada related to Article X of the Biological and Toxin Weapons Convention: Update 2016

National Rift Valley Fever Contingency Plan

DHHS-Malawi, MCH & HIV Activities

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 25. Date of information: 19 June

Health Questionnaire

Risks of Emerging Infectious Diseases in ASEAN. Prasit Palittapongarnpim, M.D. Department of Microbiology, Faculty of Science, Mahidol University

Situation of AI in Egypt

Goals. Transboundary or. We are Here to Help. Awareness that animal biosecurity is addressed at the. Who s who during an outbreak

Human and Fiscal Implications of Heart Disease and Stroke

STRENGTHENING HEALTH SYSTEMS: TOWARD UNIVERSAL HEALTH COVERAGE & GLOBAL HEALTH SECURITY

Alex Bouchot, OIE Sub-Regional Representation for South East Asia

Fred Odhiambo. NPHL Launches a National Centre of excellence for Public Health Laboratory Services and Influenza Centre and a five year Strategic Plan

Mark R. Wilson, Ph.D. Chemical Biological Sciences Unit FBI Laboratory

What you need to know... Notifiable Diseases/Conditions. Alabama Department of Public Health (ADPH) Bureau of Communicable Disease - Epidemiology

Polio Eradication and Surveillance. December

Laboratory is critical component of health systems strengthening:

OIE s initiative on HPAI control

Strategies for strengthening surveillance and NIC capacities in the WHO European Region

Thailand s avian influenza control and pandemic influenza preparedness. Supamit Chunsuttiwat Ministry of Public Health 12 July 2006

Epidemic Investigation and Management By

FY 2008 Appropriations for R&D and Public Health Programs (in millions)

Regional Capacity Development and Networking Program to Improve TADs Surveillance and Control

Establishing human vaccine manufacturing in Southern Africa

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Infrastructure and Methods to Support Real Time Biosurveillance. Kenneth D. Mandl, MD, MPH Children s Hospital Boston Harvard Medical School

Transcription:

Uganda s Progress in Science Applied to Implementing Lab Saving Lives Biosafety / Biosecurity Joel Peter Opio PHS Lab Biosafety, Biosecurity and Infrastructure [Presenter Name Presenter Title] U.S. Centers for Disease Control and Prevention Uganda U.S. Centers for Disease Control and [Meeting Name] Prevention Uganda [Date Location] Biosafety Global Stakeholders Meeting September 23 rd 24 th 2015 Atlanta

Situational analysis Uganda is signatory to: Biological and Toxin Weapons Convention (BTWC, 1972) UN Security Council Resolution 1540 WHO International Health Regulation (IHR, 2005) Chemical Weapon Convention 1993

Situational Analysis Legislation and policies; Anti- Terrorism act, 2002 Occupational Health & Safety Act, 2007 Uganda National Health Laboratory Policy, 2009 Biosafety Act 2012 Biosecurity policies and bill, (draft) hope to be passed in 2015

Challenges Definitions were not clear Biosafety was poorly understood Bio was a missing prefix for all definitions of security and terrorism The National Health Laboratory Policy 2009 addressed biosafety but not biosecurity The National Health Laboratory Strategic Plan 2010 2015 only mentions biosecurity but does not plan for it.

Challenges The National Biotechnology and Biosafety Bill 2012 does not address health laboratory biosafety or biosecurity and is more agricultural. The Bill is for an Act to ensure the safe development and use of modern biotechnology; To provide mechanisms to regulate research, development and use of genetically modified organisms.

Challenges Biosafety and Biosecurity were not addressed in lab training curriculum Inadequate human resources in terms of skills and numbers Few labs implemented Biosafety and or Biosecurity Expensive to implement Poor infrastructure Poor understanding of the concepts

Critical Considerations for Biosecurity and Bioterrorism Ebola outbreaks - 2000, 2007, 2011, 2012 Marburg outbreaks - 2007, 2012 Anthrax - 2010 Yellow fever 2010, 2012 Highly perforating strain of typhoid -2009 Nodding disease since 2013 Though endemic, outbreaks of Plague, Typhoid, Cholera and Meningitis

Strategies and Accomplishments Lab infrastructure improvement Renovation of Laboratories such as the BSL-2 Enhanced labs for VHF diagnostics, influenza laboratory UHNLS under construction Strengthen Coordination MoH - National Disease Control Department National Laboratories CPHL and UVRI Formulation of the Bio-risk management Subcommittee of the National Laboratory Advisory Committee

Strategies and Accomplishments Improvement of surveillance Strengthened community component Plague influenza, yellow fever, marburg, Ebola, meningitis, anthrax, botulism. Development of the National Biosecurity Bill (draft) and draft Policy used as a working document Specific Training in biosafety

Strategies and Accomplishments Development of the National Specimen Referral and Transportation Network Improved Identification of Pathogen Improved skills of personnel in referral labs Implementation of QA through SLMTA program (Strengthening Laboratories Management to Towards Accreditation) Establishment of the EOC real time reporting of cases.

Strategies and Accomplishments 33 person ToTs in Biosafety and Biosecurity ( 8 trained in ACILT South Africa) More than 700 laboratory personnel trained in biosafety Biosafety officers are mandatory designated positions for all laboratory facilities

Strategies and Accomplishments 2 Biomedical Engineers trained at Eagleson Institute, USA on BSC certification and maintenance Perimeter wall construction at UVRI and National Animal Disease Diagnostic Epidemiological Center (NADDEC) Access control to UVRI and NADDEC

Where are we now (1) Developed Laboratory Biosafety Manual Harmonization of national Curriculum for biosafety trainings National biosafety implementation plan Baseline biosafety assessment of the 100 laboratory hubs under way

Where are we now (2) Uganda Government recognition of Biosafety and Biosecurity; Establishment of a college specializing on Biosecurity training at College of Vetinary Medicine and Biosecurity (COVAB) at Makerere University Demonstrated that Global health Security Agenda works

Current Challenges Sustainability of existing infrastructure and programmes; most are donor driven efforts Cost of equipment and technology is high and ever-changing calling for a stable financial environment Culture of Biosafety and Biosecurity is still slow to acquire. Lack of standard body to certify in-country biosafety professionals

Acknowledgements CDC Dr. Christina Mwangi Biological Engagement Program USG Department of Defense WHO Sandia National Laboratories ACILT, South Africa Ministry Of Health Uganda Lab Branch Team CDC-Uganda

Science Applied to Saving Lives Thank you [Presenter Name Presenter Title] U.S. Centers for Disease Control and Prevention Uganda [Meeting Name] [Date Location]